ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/5/2026ACC: 0001867033-26-000002
Officer· Interim CFO
Since Jun 2021
-7.86K
Net shares
Net seller
$4.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
7.86K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.86K
Price / share
$0.58
Trade value
$4.56K
% of position
7.0%
12/31/2025
111.65K→103.80K
Total
Net shares
−7.86K
Net value
-$4.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | F · Tax Withholding | −7.86K | $0.58 | $4.56K | 7.0% | 111.65K | 103.80K |
| Total | −7.86K | -$4.56K | ||||||
Derivative Transactions0
No derivative transactions reported